Feedback

EMA sees no reason to refuse from AstraZeneca vaccine

Source : 112 Ukraine

According to EMA Director, the number of the appearance of such side effects is not major in comparison with the total number of vaccinated people and the advantages of the drug surpass the risks
11:41, 17 March 2021

Open source

The European Medicines Agency (EMA) does not have evidence that Oxford/AstraZeneca vaccine from Covid-19 might cause thrombosis, as DW reported citing EMA Director Emer Cook.

According to her, the number of the appearance of such side effects is not major in comparison with the total number of vaccinated people and the advantages of the drug surpass the risks. She noted that the cases of thrombosis were detected not during the clinical trials of the vaccine and they are not included on the list of side effects.

Related: Ukraine’s PM offers to lift responsibility for consequences from producers of Covid-19 vaccines

Earlier, the EMA Pharmacovigilance Risk Assessment Committee earlier discussed cases of thrombosis after the AstraZeneca vaccine and it will provide conclusions on March 18. Emer Cook said that the EMA expert ‘will consult on whether or not some measures should be assumed in the future,” Cook explained.

Due to the blood clots, some countries stopped the use of the AstraZeneca vaccine; particularly, Denmark, Austria, Estonia, Lithuania, Luxembourg, Latvia and Cyprus. Norway is not an EU member but it also stopped the use of AstraZeneca. Later, Bulgaria, Thailand, and Romania joined this list. Soon, Ireland and the Netherlands also refused fro AstraZeneca’s use.

Related: WHO expects new vaccines from Covid-19, - media

Germany, France, and Italy also confirmed the refusal of the AstraZeneca vaccine.

In Norway, three medics were hospitalized with blood clots. While a woman died after AstraZeneca shot in Croatia.

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more